Trial · NCT00704847
Results by group40
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 40
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Joint Space Width (JSW) in the Medial Tibia-femoral Knee Joint in the Signal Knee Measured by X-ray Change From Baseline Over 24 Months | SMC021 Oral Calcitonin | -0.32 | Standard Deviation 0.693 | mm | |
| Joint Space Width (JSW) in the Medial Tibia-femoral Knee Joint in the Signal Knee Measured by X-ray Change From Baseline Over 24 Months | SMC021 Placebo | -0.40 | Standard Deviation 0.768 | mm | |
| Pain Subscore Change From Baseline Over 24 Months as Assessed by Western Ontario and McMaster Universities Arthritis (WOMAC) Index | SMC021 Oral Calcitonin | -80.6 | Standard Deviation 112.22 | Units on a scale | |
| Pain Subscore Change From Baseline Over 24 Months as Assessed by Western Ontario and McMaster Universities Arthritis (WOMAC) Index | SMC021 Placebo | -87.9 | Standard Deviation 116.25 | Units on a scale | |
| Bone & Cartilage Metabolism Biochemical Marker Change (Percentage). | SMC021 Oral Calcitonin | Serum CTX-I (ng/mL) | 50.6 | Standard Deviation 83.74 | percentage of change |
| Bone & Cartilage Metabolism Biochemical Marker Change (Percentage). | SMC021 Placebo | Serum CTX-I (ng/mL) | 40.6 | Standard Deviation 45.52 | percentage of change |
| Bone & Cartilage Metabolism Biochemical Marker Change (Percentage). | SMC021 Oral Calcitonin | Serum Osteocalcin (ng/mL) | 3.6 | Standard Deviation 37.42 | percentage of change |
| Bone & Cartilage Metabolism Biochemical Marker Change (Percentage). | SMC021 Placebo | Serum Osteocalcin (ng/mL) | 3.9 | Standard Deviation 26.32 | percentage of change |
| Bone & Cartilage Metabolism Biochemical Marker Change (Percentage). | SMC021 Oral Calcitonin | 24-h urine CTX-I/creatinine (µg/mmol) | 9.8 | Standard Deviation 85.95 | percentage of change |
| Bone & Cartilage Metabolism Biochemical Marker Change (Percentage). | SMC021 Placebo | 24-h urine CTX-I/creatinine (µg/mmol) | 7.2 | Standard Deviation 44.36 | percentage of change |
| Bone & Cartilage Metabolism Biochemical Marker Change (Percentage). | SMC021 Oral Calcitonin | 24-h urine CTX-II/creatinine (ng/mmol) | 2.6 | Standard Deviation 63.13 | percentage of change |
| Bone & Cartilage Metabolism Biochemical Marker Change (Percentage). | SMC021 Placebo | 24-h urine CTX-II/creatinine (ng/mmol) | 2.3 | Standard Deviation 51.07 | percentage of change |
| Knee Disease Progression Assessed by MRI | SMC021 Oral Calcitonin | Cartilage Volume Month 12 | 3.4 | Standard Deviation 9.11 | percentage of change |
| Knee Disease Progression Assessed by MRI | SMC021 Placebo | Cartilage Volume Month 12 | 3.0 | Standard Deviation 13.16 | percentage of change |
| Knee Disease Progression Assessed by MRI | SMC021 Oral Calcitonin | Cartilage Volume Month 24 | 2.6 | Standard Deviation 10.18 | percentage of change |
| Knee Disease Progression Assessed by MRI | SMC021 Placebo | Cartilage Volume Month 24 | 3.5 | Standard Deviation 12.73 | percentage of change |
| Knee Disease Progression Assessed by MRI | SMC021 Oral Calcitonin | Cartilage Thickness Month 12 | 4.7 | Standard Deviation 10.64 | percentage of change |
| Knee Disease Progression Assessed by MRI | SMC021 Placebo | Cartilage Thickness Month 12 | 4.7 | Standard Deviation 8.24 | percentage of change |
| Knee Disease Progression Assessed by MRI | SMC021 Oral Calcitonin | Cartilage Thickness Month 24 | 4.5 | Standard Deviation 10.78 | percentage of change |
| Knee Disease Progression Assessed by MRI | SMC021 Placebo | Cartilage Thickness Month 24 | 4.1 | Standard Deviation 8.67 | percentage of change |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00704847/results